These cell lines stem from disparate tumor or tissue types, but they were all predicted to have very high recruitment of CRKL (more than one copy of CRKL bound to each molecule of IGF1R) coupled with moderately high recruitment of either SRC, SHC1, or RASA1. The gene discussed is SRC; the disease is neoplasm.